The clinical picture of acute and chronic hepatitis C

Current Studies in Hematology and Blood Transfusion

Volumn 62, Issue , 1998, Pages 102-118

  Esteban, Juan I ^a   Cordoba, Joan ^a   Sauleda, Silvia ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CLINICAL FEATURE; DRUG DEPENDENCE; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MOLECULAR CLONING; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS TRANSMISSION;

ACUTE DISEASE; CLINICAL TRIALS; DISEASE PROGRESSION; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; TREATMENT OUTCOME;

EID: 0031882970     PISSN: 02580330     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060474     Document Type: Article

References (93)

1. Feinstone SM, Kapikian AZ, Purcell RH, et al: Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 1975;292:767-770.
2. Prince AM, Brotman B, Grady GF, et al: Long incubation period post-transfusion hepatitis without serological evidence of exposure to hepatitis B virus. Lancet 1974;ii:241-246.
3. Dienstag JL: Non-A, non-B hepatitis. I. Recognition, epidemiology and clinical features. Gastroenterology 1983;85:439-462.
4. Alter HJ, Purcell RH, Holland PV, et al: Clinical and serological analysis of transfusion-associated hepatitis. Lancet 1975;2:838-841.
5. Aach RD, Lander JI, Sherman LA, et al: Transfusion-transmitted viruses: Interim analysis of hepatitis among transfused and non-transfused patients; in Vyas GN, Cohen SN, Schmid R (eds): Viral Hepatitis. Philadelphia, Franklin Institute Press, 1978, pp 383-396.
6. Seeff LB, Zimmermann HJ, Wright EC, et al: A randomized double blind controlled trial of the efficacy of immune serum globulin for the prevention of postransfusion hepatitis: A Veterans Administration Cooperative Study. Gastroenterology 1977;72:111-121.
7. Alter HJ: Chronic consequences of non-A, non-B hepatitis; in Seef LB, Lewis JH (eds): Current Prospective in Hepatology. New York, Plenum Publishing, 1989, pp 83-97.
8. Knodell RG, Conrad ME, Dienstag JL, et al: Etiological spectrum of postransfusion hepatitis. Gastroenterology 1978;74:121-131.
9. Shih JWK, Esteban JI, Alter HJ: Non-A, non-B hepatitis: Advances and unfulfilled expectations of the first decade; in Popper H, Schaffner F (eds): Progress in Liver Diseases. New York, Grunne & Stratton, 1986, vol 8, pp 433-452.
10. Alter HJ: The hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitis. J Gastroenterol Hepatol 1990;(suppl 1):78-94.
11. Genesca J, Esteban JI, Alter HJ: Blood-borne non-A, non-B hepatitis: Hepatitis C. Semin Liver Dis 1991;11:147-164.
12. Colombo M, Oldani S, Donato MF, Borzio M, Santese R, Roffi L, Vigano P, Cargnel A: A multicenter prospective study of postransfusion hepatitis in Milan. Hepatology 1987;7:709-712.
13. Pastore G, Mono L, Santantonio T, Angarano G, Trotta F, Schiraldi O: Monophasic and polyphasic pattern of alanine aminotransferase in acute non-A, non-B hepatitis. Clinical and prognostic implications. Hepatogastroenterology 1985;32:155-158.
14. Sampliner RE, Woronow DI, Alter MJ, et al: Community acquired non-A, non-B hepatitis. Clinical characteristics and chronicity. J Med Virol 1984; 13:125-130.
15. Esteban JI, Gonzalez A, Hernández JM, Viladomiu L, Sánchez C, López-Talavera JC, Lucea D, Martin-Vega C, Vidal X, Esteban R, et al: Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990;323:1107-1112.
16. Wang TH, Wang JT, Lin JT, Sheu JC, Sung JL, Chen DS: A prospective study of posttransfusion hepatitis in Taiwan. J Hepatol 1991;13:38-43.
17. Miyamura T, Saito I, Katayama T, Kikuchi S, Tateda A, Houghton M, Choo QL, Kuo G: Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: Application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci USA 1990;87:983-987.
18. Tremolada F, Casarin C, Tagger A, Ribero ML, Realdi G, Alberti A, Ruol A: Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med 1991;114:277-281.
19. Lee ST, Hwang SJ, Lu RH, Lai KH, Tsai YT, Lo KJ: Antibodies to hepatitis C virus in prospective followed patients with posttransfusion hepatitis. J Infect Dis 1991;163:1354-1357.
20. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ: Hepatitis C virus infection in post-transfusion hepatitis. N Engl J Med 1991;325: 1325-1329.
21. Mattson L, Weiland O, Glaumann H: Chronic non-A, non-B hepatitis developed after transfusion, illicit self injections or sporadically. Outcome during long-term follow-up. A comparison. Liver 1989;9:120-127.
22. DiBisceglie AM, Goodman ZD, Ishak KG, Hoofagle JH, Melpolder JJ, Alter HJ: Long-term clinical and histopathological follow-up of chronic postransfusion hepatitis. Hepatology 1991;14:969-974
23. Tanaka E, Kiyosawa K, Sodeyama T, Nakano Y, Yoshizawa K, Hayata T, Shimizu S, Nakatsuji Y, Koike Y, Furuta S: Significance of antibodies to hepatitis C virus in Japanese patients with viral hepatitis. J Med Virol 1991;33:117-122.
24. Barrera JM, Bruguera M, Ercilla MG, Sanchez-Tapias JM, Costa J, Gelabert A, Castillo R, Rodes J: Hepatitis postransfusional después de cirugía cardíaca. Incidencia, clínica y pronóstico. Med Clin (Barc) 1987;89:759-762.
25. Meyers JD, Dienstag JL, Purcell RH, Thomas LD, Holmes KK: Parenterally-transmitted non-A, non-B hepatitis: An epidemic reassessed. Ann Intern Med 1977;87:57-59.
26. Wejstal R, Lindberg J, Lundin P, Norkrans G: Chronic non-A, non-B hepatitis. A long-term follow-up study in 49 patients. Scand J Gastroenterol 1987;22:1115-1122.
27. Wejstal R, Hermodsson S, Norkrans G: Long-term follow-up of chronic hepatitis non-A, non-B with especial reference to hepatitis C. Liver 1991;11:143-148.
28. Mattson S, Weiland O, Glaumann H: Long-term follow-up of chronic postransfusion non-A, non-B hepatitis: Clinical and histological outcome. Liver 1988;8:184-188.
29. Mattson S, Weiland O, Glaumann H. Application of a numerical scoring system for assessment of histological outcome in patients with chronic postransfusion non-A, non-B hepatitis with or without antibodies to hepatitis C. Liver 1990;10:257-263.
30. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, et al: The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-I905.
31. Norkrans G, Frosner G, Herdnondson H, Iwarson S: Clinical and epidemiological and prognostic aspects of hepatitis non-A, non-B. A comparison with hepatitis A and B. Scand J Infect Dis 1979; 11:259-264.
32. Nagata A, Kiyosawa K, Koike Y, Miura M, Gibo Y, Sodeyama T, Wada S, Akahane Y, Furuta S: Epidemiology of sporadic acute non-A, non-B hepatitis in Japan. A comparison with hepatitis A and B. Am J Gastroenterol 1985;80:298-302.
33. Prince AM, Brotman B, Huima T, Pascual D, Jaffery M, Inchauspe G: Immunity in hepatitis C infection. J Infect Dis 1992;165:438-443.
34. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, et al: Lack of protective immunity against reinfection with hepatitis C virus. Science 1992;258:135-140.
35. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A, Farci P: Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994; 343:388-390.
36. Wright TL, Hsu H, Donegan E, Feinstone S, Greenberg H, Read A, Ascher NL, Roberts JP, Lake JR: Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med 1991;115: 111-112.
37. Pereira BJ, Milford EL, Kirkman RL, Levey AS: Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991;325:454-460.
38. Onishi H, Sugihara J, Moriwaki H, Muto Y: Detection of anti-hepatitis C virus antibody in fulminant hepatic failure. Gastroenterol Jpn 1991;26(suppl 3):212-215.
39. Mimms LT, Barbosa L, Cunningham M, et al: Coinfection of HCV and HBV in postransfusion hepatitis patients from the transfusion-transmitted viruses study. Hepatology 1992;16/4:69A.
40. Tandon BN, Irshad M, Acharya SK, Joshi YK: Hepatitis C virus infection is the major cause of severe liver disease in India. Gastroenterol Jpn 1991;26(suppl 3):192-195.
41. Thaler M, Hu F, Heyman MB: Giant cell hepatitis due to hepatitis C virus infection. Hepatology 1992;16/4:74A.
42. Pol S, Theirs V, Driss F, Devergie A, Berthelot P, Brechot C, Gluckman E: Lack of evidence for a role of HCV in hepatitis-associated aplastic anemia. Br J Haematol 1993;85:808-810.
43. Shibata M, Morishima T, Kudo T, Maki T, Maki S, Nagai Y: Serum hepatitis C virus sequences in postransfusion non-A, non-B hepatitis. Blood 1991;77:1157-1160.
44. McHutchison JG, Chung RT, Redeker AG, Dienstag JL, Kaplan LM: Loss of serologic markers and viral RNA does not reliably predict eradication of chronic hepatitis C virus infection. Hepatology 1991;14/4:79A.
45. Esteban JI, Lopez-Talavera JC, Genesca J, Madoz P, Viladomiu L, Muñiz E, Martin-Vega C, Rosell M, Allende H, Vidai X, et al: High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991;115:443-449.
46. Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, Hoofnagle JH: Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991;115:700-704.
47. Balart L, Perrillo R, Roddenberry J, et al: Loss of liver HCV RNA does not predict sustained response in patients treated with alpha interferon. Hepatology 1992;16/4:74A.
48. Koff RS, Dienstag JL: Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 1995;15:101-109.
49. Mishiro S, Hoshi Y, Takeda K, Yoshikawa A, Gotanda T, Takahashi K, Akahane Y, Yoshizawa H, Okamoto H, Tsuda F, et al: Non-A, non-B specific antibodies directed at host-derived epitope: Implication for an autoimmune process. Lancet 1990;336:1400-1403.
50. Lons T, Richardet JP, Johanet C, et al: Prevalence and specificity of serum antiorganelle antibodies in patients with chronic hepatitis C. Hepatology 1992;16/2:74A.
51. Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y, Valla D, Borotto E, Yamamoto AM, Huraux JM, et al: Liver-kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992;16:630-636.
52. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Fosella PV, Pasero G, Bombardieri S: Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991; 34:1606-1610.
53. Misiani R, Bellaveta P, Fenili D, Borelli G, Marchesi D, Massazza M, Vendramin G, Comotti B, Tanzi E, Scudeller G, et al: Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992;117:573-577.
54. Durand JM, Kaplanski G, Lefevre P, Richard MA, Andrac L, Trepo C, Soubeyrand J: Effect of interferon alpha2b on cryoglobulinemia related to hepatitis C virus infection. J Infect Dis 1992;165:778-779.
55. Willson RA: Extrahepatic manifestations of chronic viral hepatitis; in Willson RA (ed): Viral Hepatitis. Diagnosis, Treatment, Prevention. New York, Dekker, 1997, pp 331-369.
56. Cacoub P, Lunel-Fabiani F, Huong-Du LT: Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992;116:605-606.
57. Johnson RV, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, et al: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-470.
58. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, Mal F, Callard P, Beaugrand M: Lymphocytic sialadenitis of Sjögren syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-323.
59. Navas S, Bosch O, Castillo I, Marriott E, Carreno V: Porphyria cutanea tarda and hepatitis B and C viruses infection: A retrospective study. Hepatology 1995;21:279-284.
60. Andreone P, Cursaro C, Gramanizi A, Guidetti MS, Bardazzi F, Tosti A, Miniero R: Detection of hepatitis C virus by polymerase chain reaction and recombinant immunoblot assay 3.0 in porphyria cutanca tarda. Hepatology 1995;21:1754-1755.
61. Sánchez-Tapias JM, Barrera J, Costa J, Ercilla MG, Pares A, Comalrrena L, Soley F, Bruix J, Calvet X, Gil MP, et al: Hepatitis C virus infection in patients with nonalcoholic chronic liver disease. Ann Intern Med 1990;112:921-924.
62. Hopf U, Möller B, Küther D, Stmerowicz R, Lobeck H, Lüdtke-Handjery A, Walter E, Blum HE, Roggendorf M, Deinhardt F: Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 1990; 10:69-76.
63. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, Hashimoto E, Lefkowitch JH, Ludwig J, Okuda K: The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23:1334-1340.
64. Kage M, Shimamatu K, Narashima E, Kojiro M, Inoue O, Yano M: Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: Morphometric analysis of repeated biopsies. Hepatology 1997;25:1028-1031.
65. Poynard T, Bedossa P, Opolon P: Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-832.
66. Fattovich G, Tagger A, Brollo L, Giustina G, Pontisso P, Realdi G, Alberti A, Ruol A: Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis 1991;163:400-402.
67. Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH: The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991;14:64-67.
68. Taliani G, Lecce R, Badolato MC, De Bac C, De Marzio E, Balzano C, Artini M, Levrero M: A second-generation hepatitis C virus confirmatory test for chronic hepatitis B virus infection. J Infect Dis 1992;165:180-181.
69. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH: Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989;97:1559-1561.
70. Rockstroh JK, Spengler U, Sudhop T, Ewig S, Theisen A, Hammerstein U, Bierhoff E, Fischer HP, Oldenburg J, Brackmann HH, Sauerbruch T: Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol 1996;91:2563-2568.
71. Soto B, Sanchez-Quijano A, Rodrigo L, del Olmom JA, Garcia-Bengoechea M, Hernandez-Quero J, Rey C, Abad MA, Rodriguez M, Sales Gilabert M, Gonzalez F, Miron P, Caruz A, Relimpio F, Torronteras R, Leal M, Lissen E: Human immunodeficiency virus infection modifies the natural history of chronic parenterally acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997;26:1-5.
72. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T: Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994; 331:1607-1611.
73. Ferrel LD, Wright TL, Roberts J, Asher N, Lake J: Hepatitis C viral infection in liver transplant recipients. Hepatology 1992;16:865-876.
74. Böker KHW, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, Oldhaver K, Bode U, Pichlmayr R, Manns MP: Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997;25:203-210.
75. Pares A, Barrera JM, Caballeria J, Ercilla G, Bruguera M, Caballeria LL, Castillo R, Rodes J: Hepatitis C virus antibodies in chronic alcoholic patients: Associations with severity of liver injury. Hepatology 1990;12:1295-1299.
76. Nalpas D, Driss F, Pol S, Hamelin B, Housset C, Brechot C, Berthelot P: Association between HCV and HVB infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatology 1991;12:70-74.
77. Takase S, Takada N, Enomoto N, Yasuhara M, Takada A: Different types of chronic hepatitis in alcoholic patients: Does chronic hepatitis induced by alcohol exist? Hepatology 1991;13:876-881.
78. Noguchi O, Yamaoka K, Ikeda T, Tozuka S, Sakamoto S, Kanayama M, Uchida T: Clinicopathological analysis of alcoholic liver disease complicating chronic type C hepatitis. Liver 1991;11:225-230.
79. Mendenhall CL, Seeff L, Diehl AM, Ghosn SJ, French SW, Gartside PS, et al: Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance. Hepatology 1991;14:581-589.
80. Nishigushi S, Kuroki T, Yabusako T, Seki S, Kobayashi K, Monna T, Otani S, Sakurai M, Shikata T, Yamamoto S: Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology 1991;14:985-989.
81. Shiomi S, Kuroki T, Minamitami S, Ueda T, Nishiguchi S, Nakajima S, Seki S, Kobayashi K, Harihara S: Effect of drinking in the outcome of cirrhosis in patients with hepatitis B or C. J Gastroenterol Hepatol 1992;7:274-276.
82. Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ: Chronic hepatitis C: Effect of alcohol on hepatitic activity and viral titre. J Hepatol 1996;25:821-826.
83. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshiazawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, et al: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma. Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12:671-675.
84. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB, Gitnick G, Knodell RG, Perrillo RP, et al: Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-1911.
85. Koretz RL, Abbey H, Coleman E, Gitnick G: Non-A, non-B postransfusion hepatitis: Looking back in the second decade. Ann Intern Med 1993;119:110-115.
86. Takahashi M, Miyamoto R, Doi T, Endo H, Tsuji T: Natural history of chronic hepatitis C. Am J Gastroenterol 1993;88:240-243.
87. Tong MJ, El-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.
88. Crowe J, Doyle C, Fielding JF, et al: Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation. Gastroenterology 1995;108:A1054.
89. Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, Ascher NL, Roberts J, Wright TL: Hepatitis C in patients undergoing liver transplantation. Ann Intern Med 1991;114: 282-284.
90. Bellentari S, Tribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, Cristianini G: Prevalence of chronic liver disease in the general population of Northern Italy: The Dionysos Study. Hepatology 1994;20:1442-1449.
91. Seeff LB, Group NS: Mortality and morbidity of transfusion-associated type C hepatitis: An NHLBI multi-center study. Hepatology 1994;20:A204.
92. Seeff LB: Natural history of viral hepatitis type C. Semin Gastrointest Dis 1995;6:20-27.
93. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, Solinas A, Mura D, Brouwer JT, Thomas H, Njapoum C, Casarin C, Bonetti P, Fuschi P, Basho J, Tocco A, Bhalla A, Galassini R, Noventa F, Schalm SW, Realdi G: Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-472.